Sarah M Nikkel1. 1. Provinical Medical Genetics Program, BC Women's Hospital and Health Centre, University of British Columbia, 4500 Oak Street, Vancouver, BC, V6H 3N1, Canada. sarah.nikkel@cw.bc.ca.
Abstract
PURPOSE OF REVIEW: This review highlights how skeletal dysplasias are diagnosed and how our understanding of some of these conditions has now translated to treatment options. RECENT FINDINGS: The use of multigene panels, using next-generation sequence technology, has improved our ability to quickly identify the genetic etiology, which can impact management. There are successes with the use of growth hormone in individuals with SHOX deficiencies, asfotase alfa in hypophosphatasia, and some promising data for c-type natriuretic peptide for those with achondroplasia. One needs to consider that a patient with short stature has a skeletal dysplasia as options for management may be available.
PURPOSE OF REVIEW: This review highlights how skeletal dysplasias are diagnosed and how our understanding of some of these conditions has now translated to treatment options. RECENT FINDINGS: The use of multigene panels, using next-generation sequence technology, has improved our ability to quickly identify the genetic etiology, which can impact management. There are successes with the use of growth hormone in individuals with SHOX deficiencies, asfotase alfa in hypophosphatasia, and some promising data for c-type natriuretic peptide for those with achondroplasia. One needs to consider that a patient with short stature has a skeletal dysplasia as options for management may be available.
Authors: David Tunkel; Yewande Alade; Richard Kerbavaz; Beth Smith; Danielle Rose-Hardison; Julie Hoover-Fong Journal: Am J Med Genet A Date: 2012-05-24 Impact factor: 2.802
Authors: Daniel J Wendt; Melita Dvorak-Ewell; Sherry Bullens; Florence Lorget; Sean M Bell; Jeff Peng; Sianna Castillo; Mika Aoyagi-Scharber; Charles A O'Neill; Pavel Krejci; William R Wilcox; David L Rimoin; Stuart Bunting Journal: J Pharmacol Exp Ther Date: 2015-02-03 Impact factor: 4.030
Authors: Shunji Tomatsu; Kazuki Sawamoto; Tsutomu Shimada; Michael B Bober; Francyne Kubaski; Eriko Yasuda; Robert W Mason; Shaukat Khan; Carlos J Alméciga-Díaz; Luis A Barrera; William G Mackenzie; Tadao Orii Journal: Expert Opin Orphan Drugs Date: 2015-10-29 Impact factor: 0.694
Authors: Florence Lorget; Nabil Kaci; Jeff Peng; Catherine Benoist-Lasselin; Emilie Mugniery; Todd Oppeneer; Dan J Wendt; Sean M Bell; Sherry Bullens; Stuart Bunting; Laurie S Tsuruda; Charles A O'Neill; Federico Di Rocco; Arnold Munnich; Laurence Legeai-Mallet Journal: Am J Hum Genet Date: 2012-11-29 Impact factor: 11.025
Authors: Maria Claudia Jurcă; Sânziana Iulia Jurcă; Filip Mirodot; Bogdan Bercea; Emilia Maria Severin; Marius Bembea; Alexandru Daniel Jurcă Journal: Rom J Morphol Embryol Date: 2021 Jul-Sep Impact factor: 0.833